SERENASE

Main information

  • Trade name:
  • SERENASE 1 mg tablet
  • Dosage:
  • 1 mg
  • Pharmaceutical form:
  • tablet
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • SERENASE 1 mg tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Haloperidol
  • Product summary:
  • Suitability for use in older adult patients Haloperidolum Avoid using in older persons. Slightly anticholinergic. Slightly sedative. Risk of QT prolongation. Significant adverse effects include cognitive disorder, confusion, extrapyramidal symptoms, orthostatic hypotension, risk of cardiovascular events and risk of falls. Non-pharmacological treatments are the first line approach in the management of behavioral and psychological symptoms of dementia.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 710
  • Authorization date:
  • 10-07-2008
  • Last update:
  • 21-02-2018